The formation of new blood vessels after myocardial infarction (MI) is essential for the survival of existing and regenerated cardiac tissue. However, the extent of endogenous revascularization after MI is insufficient, and MI can often result in ventricular remodelling, progression to heart failure and premature death. The neutral results of numerous clinical trials that have evaluated the efficacy of angiogenic therapy to revascularize the infarcted heart reflect our poor understanding of the processes required to form a functional coronary vasculature. In this Review, we describe the latest advances in our understanding of the processes involved in coronary vessel formation, with mechanistic insights taken from developmental studies. Coronary vessels originate from multiple cellular sources during development and form through a number of distinct and carefully orchestrated processes. The ectopic reactivation of developmental programmes has been proposed as a new paradigm for regenerative medicine, therefore, a complete understanding of these processes is crucial. Furthermore, knowledge of how these processes differ between the embryonic and adult heart, and how they might be more closely recapitulated after injury are critical for our understanding of regenerative biology, and might facilitate the identification of tractable molecular targets to therapeutically promote neovascularization and regeneration of the infarcted heart.
The coronary vasculature is established in mammals during embryonic and neonatal development, with endothelial cells derived predominantly from the sinus venosus and the endocardium, and mural cells mainly from the epicardium.
Neovascularization after myocardial infarction is essential for the restoration of blood flow to the injured myocardium, but the endogenous mechanisms by which new vessels grow is poorly understood.
To date, no effective treatment to induce coronary neovascularization has been identified.
The neonatal mouse heart has greater regenerative capacity than the adult mouse heart.
The regulatory pathways that control angiogenesis during development are activated in the injured myocardium in the neonatal mouse heart, but are repressed or not activated in the infarct region in the adult mouse heart.
Genetic cell lineage tracing and single-cell transcriptomic analyses might provide insights into mechanisms that can be targeted to increase the neovascularization and regeneration of the injured myocardium.
Subscribe to Journal
Get full journal access for 1 year
only $17.42 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Padro, T. et al. ESC Working Group on Coronary Pathophysiology and Microcirculation position paper on ‘coronary microvascular dysfunction in cardiovascular disease’. Cardiovasc. Res. 116, 741–755 (2020).
Seiler, C., Stoller, M., Pitt, B. & Meier, P. The human coronary collateral circulation: development and clinical importance. Eur. Heart J. 34, 2674–2682 (2013).
Reffelmann, T. & Kloner, R. A. The no-reflow phenomenon: a basic mechanism of myocardial ischemia and reperfusion. Basic. Res. Cardiol. 101, 359–372 (2006).
Regenfus, M. et al. Six-year prognostic value of microvascular obstruction after reperfused ST-elevation myocardial infarction as assessed by contrast-enhanced cardiovascular magnetic resonance. Am. J. Cardiol. 116, 1022–1027 (2015).
Giacca, M. & Zacchigna, S. VEGF gene therapy: therapeutic angiogenesis in the clinic and beyond. Gene Ther. 19, 622–629 (2012).
Stewart, D. J. et al. VEGF gene therapy fails to improve perfusion of ischemic myocardium in patients with advanced coronary disease: results of the NORTHERN trial. Mol. Ther. 17, 1109–1115 (2009).
Henry, T. D. et al. The VIVA trial: vascular endothelial growth factor in ischemia for vascular angiogenesis. Circulation 107, 1359–1365 (2003).
Simons, M. et al. Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial. Circulation 105, 788–793 (2002).
Yu, A. Y. et al. Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1α. J. Clin. Invest. 103, 691–696 (1999).
Siu, C. W., Liao, S. Y., Liu, Y., Lian, Q. & Tse, H. F. Stem cells for myocardial repair. Thrombosis Haemost. 104, 6–12 (2010).
Lindsey, M. L. et al. A novel collagen matricryptin reduces left ventricular dilation post-myocardial infarction by promoting scar formation and angiogenesis. J. Am. Coll. Cardiol. 66, 1364–1374 (2015).
He, L. et al. Preexisting endothelial cells mediate cardiac neovascularization after injury. J. Clin. Invest. 127, 2968–2981 (2017).
Fiedler, J. et al. Development of long noncoding RNA-based strategies to modulate tissue vascularization. J. Am. Coll. Cardiol. 66, 2005–2015 (2015).
Xu, Z. M., Huang, F. & Huang, W. Q. Angiogenic lncRNAs: a potential therapeutic target for ischaemic heart disease. Life Sci. 211, 157–171 (2018).
Fan, Z. G. et al. MicroRNA-210 promotes angiogenesis in acute myocardial infarction. Mol. Med. Rep. 17, 5658–5665 (2018).
Tseliou, E. et al. Angiogenesis, cardiomyocyte proliferation and anti-fibrotic effects underlie structural preservation post-infarction by intramyocardially-injected cardiospheres. PLoS ONE 9, e88590 (2014).
Zhao, L., Johnson, T. & Liu, D. Therapeutic angiogenesis of adipose-derived stem cells for ischemic diseases. Stem Cell Res. Ther. 8, 125 (2017).
Vrijsen, K. R. et al. Exosomes from cardiomyocyte progenitor cells and mesenchymal stem cells stimulate angiogenesis via EMMPRIN. Adv. Healthc. Mater. 5, 2555–2565 (2016).
Bollini, S. et al. Re-activated adult epicardial progenitor cells are a heterogeneous population molecularly distinct from their embryonic counterparts. Stem Cell Dev. 23, 1719–1730 (2014).
Dubé, K. N. et al. Recapitulation of developmental mechanisms to revascularize the ischemic heart. JCI Insight 2, e96800 (2017).
Reese, D. E., Mikawa, T. & Bader, D. M. Development of the coronary vessel system. Circ. Res. 91, 761–768 (2002).
Norman, S. & Riley, P. R. Anatomy and development of the cardiac lymphatic vasculature: its role in injury and disease. Clin. Anat. 29, 305–315 (2016).
Ratajska, A. et al. Comparative and developmental anatomy of cardiac lymphatics. ScientificWorldJournal 2014, 183170 (2014).
Conway, E. M., Collen, D. & Carmeliet, P. Molecular mechanisms of blood vessel growth. Cardiovasc. Res. 49, 507–521 (2001).
Pinto, A. R. et al. Revisiting cardiac cellular composition. Circ. Res. 118, 400–409 (2016).
Hu, N., Yost, H. J. & Clark, E. B. Cardiac morphology and blood pressure in the adult zebrafish. Anat. Rec. 264, 1–12 (2001).
Kapuria, S., Yoshida, T. & Lien, C. L. Coronary vasculature in cardiac development and regeneration. J. Cardiovasc. Dev. Dis. 5, 59 (2018).
Hutchins, G. M., Kessler-Hanna, A. & Moore, G. W. Development of the coronary arteries in the embryonic human heart. Circulation 77, 1250–1257 (1988).
Bogers, A. J., Gittenberger-de Groot, A. C., Poelmann, R. E., Peault, B. M. & Huysmans, H. A. Development of the origin of the coronary arteries, a matter of ingrowth or outgrowth? Anat. Embryol. 180, 437–441 (1989).
Tian, X. et al. Peritruncal coronary endothelial cells contribute to proximal coronary artery stems and their aortic orifices in the mouse heart. PLoS ONE 8, e80857 (2013).
Mikawa, T. & Fischman, D. A. Retroviral analysis of cardiac morphogenesis: discontinuous formation of coronary vessels. Proc. Natl Acad. Sci. USA 89, 9504–9508 (1992).
Gittenberger-de Groot, A. C., Eralp, I., Lie-Venema, H., Bartelings, M. M. & Poelmann, R. E. Development of the coronary vasculature and its implications for coronary abnormalities in general and specifically in pulmonary atresia without ventricular septal defect. Acta Paediatr. Suppl. 93, 13–19 (2004).
Gittenberger-de Groot, A. C., Vrancken Peeters, M. P., Bergwerff, M., Mentink, M. M. & Poelmann, R. E. Epicardial outgrowth inhibition leads to compensatory mesothelial outflow tract collar and abnormal cardiac septation and coronary formation. Circ. Res. 87, 969–971 (2000).
Cai, C. L. et al. A myocardial lineage derives from Tbx18 epicardial cells. Nature 454, 104–108 (2008).
Acharya, A., Baek, S. T., Banfi, S., Eskiocak, B. & Tallquist, M. D. Efficient inducible Cre-mediated recombination in Tcf21 cell lineages in the heart and kidney. Genesis 49, 870–877 (2011).
Red-Horse, K., Ueno, H., Weissman, I. L. & Krasnow, M. A. Coronary arteries form by developmental reprogramming of venous cells. Nature 464, 549–553 (2010).
Wu, B. et al. Endocardial cells form the coronary arteries by angiogenesis through myocardial-endocardial VEGF signaling. Cell 151, 1083–1096 (2012).
Zhang, H. et al. Endocardium minimally contributes to coronary endothelium in the embryonic ventricular free walls. Circ. Res. 118, 1880–1893 (2016).
Tian, X. et al. Vessel formation. De novo formation of a distinct coronary vascular population in neonatal heart. Science 345, 90–94 (2014).
Su, T. et al. Single-cell analysis of early progenitor cells that build coronary arteries. Nature 559, 356–362 (2018).
Payne, S. et al. Regulatory pathways governing murine coronary vessel formation are dysregulated in the injured adult heart. Nat. Commun. 10, 3276 (2019).
Fang, J. S. et al. Shear-induced Notch-Cx37-p27 axis arrests endothelial cell cycle to enable arterial specification. Nat. Commun. 8, 2149 (2017).
Carmeliet, P. Angiogenesis in health and disease. Nat. Med. 9, 653–660 (2003).
Harrison, M. R. et al. Chemokine-guided angiogenesis directs coronary vasculature formation in zebrafish. Dev. Cell 33, 442–454 (2015).
Cano, E. et al. Extracardiac septum transversum/proepicardial endothelial cells pattern embryonic coronary arterio-venous connections. Proc. Natl Acad. Sci. USA 113, 656–661 (2016).
Cossette, S. & Misra, R. The identification of different endothelial cell populations within the mouse proepicardium. Dev. Dyn. 240, 2344–2353 (2011).
Zhou, B. & Pu, W. T. Genetic Cre-loxP assessment of epicardial cell fate using Wt1-driven Cre alleles. Circ. Res. 111, e276–e280 (2012).
Pu, W. et al. Genetic targeting of organ-specific blood vessels. Circ. Res. 123, 86–99 (2018).
Katz, T. C. et al. Distinct compartments of the proepicardial organ give rise to coronary vascular endothelial cells. Dev. Cell 22, 639–650 (2012).
Zhou, B. et al. Epicardial progenitors contribute to the cardiomyocyte lineage in the developing heart. Nature 454, 109–113 (2008).
Kamimura, T., Yamagishi, T. & Nakajima, Y. Avian coronary endothelium is a mosaic of sinus venosus- and ventricle-derived endothelial cells in a region-specific manner. Dev. Growth Differ. 60, 97–111 (2018).
Smart, N., Dube, K. N. & Riley, P. R. Coronary vessel development and insight towards neovascular therapy. Int. J. Exp. Pathol. 90, 262–283 (2009).
Chen, H. I. et al. The sinus venosus contributes to coronary vasculature through VEGFC-stimulated angiogenesis. Development 141, 4500–4512 (2014).
Tian, X. et al. Subepicardial endothelial cells invade the embryonic ventricle wall to form coronary arteries. Cell Res. 23, 1075–1090 (2013).
Sharma, B. et al. Alternative progenitor cells compensate to rebuild the coronary vasculature in elabela- and Apj-deficient hearts. Dev. Cell 42, 655–666.e3 (2017).
Olivey, H. E. & Svensson, E. C. Epicardial-myocardial signaling directing coronary vasculogenesis. Circ. Res. 106, 818–832 (2010).
Perez-Pomares, J. M. & de la Pompa, J. L. Signaling during epicardium and coronary vessel development. Circ. Res. 109, 1429–1442 (2011).
Arita, Y. et al. Myocardium-derived angiopoietin-1 is essential for coronary vein formation in the developing heart. Nat. Commun. 5, 4552 (2014).
Ivins, S. et al. The CXCL12/CXCR4 axis plays a critical role in coronary artery development. Dev. Cell 33, 455–468 (2015).
Chen, H. I. et al. VEGF-C and aortic cardiomyocytes guide coronary artery stem development. J. Clin. Invest. 124, 4899–4914 (2014).
Aghajanian, H. et al. Coronary vasculature patterning requires a novel endothelial ErbB2 holoreceptor. Nat. Commun. 7, 12038 (2016).
Chang, A. H. et al. DACH1 stimulates shear stress-guided endothelial cell migration and coronary artery growth through the CXCL12-CXCR4 signaling axis. Genes. Dev. 31, 1308–1324 (2017).
Das, S. et al. A unique collateral artery development program promotes neonatal heart regeneration. Cell 176, 1128–1142.e18 (2019).
Chen, Q. et al. Endothelial cells are progenitors of cardiac pericytes and vascular smooth muscle cells. Nat. Commun. 7, 12422 (2016).
Smith, C. L., Baek, S. T., Sung, C. Y. & Tallquist, M. D. Epicardial-derived cell epithelial-to-mesenchymal transition and fate specification require PDGF receptor signaling. Circ. Res. 108, e15–e26 (2011).
Wang, S. et al. Alterations in retinoic acid signaling affect the development of the mouse coronary vasculature. Dev. Dyn. 247, 976–991 (2018).
Wei, K. et al. Developmental origin of age-related coronary artery disease. Cardiovasc. Res. 107, 287–294 (2015).
Liu, Q. et al. Smooth muscle origin of postnatal 2nd CVP is pre-determined in early embryo. Biochem. Biophys. Res. Commun. 471, 430–436 (2016).
Acharya, A. et al. The bHLH transcription factor Tcf21 is required for lineage-specific EMT of cardiac fibroblast progenitors. Development 139, 2139–2149 (2012).
Arima, Y. et al. Preotic neural crest cells contribute to coronary artery smooth muscle involving endothelin signalling. Nat. Commun. 3, 1267 (2012).
Mellgren, A. M. et al. Platelet-derived growth factor receptor beta signaling is required for efficient epicardial cell migration and development of two distinct coronary vascular smooth muscle cell populations. Circ. Res. 103, 1393–1401 (2008).
Sinha, S., Iyer, D. & Granata, A. Embryonic origins of human vascular smooth muscle cells: implications for in vitro modeling and clinical application. Cell Mol. Life Sci. 71, 2271–2288 (2014).
Marin-Juez, R. et al. Fast revascularization of the injured area is essential to support zebrafish heart regeneration. Proc. Natl Acad. Sci. USA 113, 11237–11242 (2016).
Kumar, S. et al. Angiogenesis factor from human myocardial infarcts. Lancet 2, 364–368 (1983).
White, F. C. & Bloor, C. M. Coronary vascular remodeling and coronary resistance during chronic ischemia. Am. J. Cardiovasc. Pathol. 4, 193–202 (1992).
Shammas, N. W., Moss, A. J., Sullebarger, J. T., Gutierrez, O. H. & Rocco, T. A. Acquired coronary angiogenesis after myocardial infarction. Cardiology 83, 212–216 (1993).
Kocher, A. A. et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat. Med. 7, 430–436 (2001).
Smart, N. & Riley, P. R. The stem cell movement. Circ. Res. 102, 1155–1168 (2008).
Fujisawa, T. et al. Endothelial progenitor cells do not originate from the bone marrow. Circulation 140, 1524–1526 (2019).
Pasquinelli, G. et al. Thoracic aortas from multiorgan donors are suitable for obtaining resident angiogenic mesenchymal stromal cells. Stem Cell 25, 1627–1634 (2007).
Klein, D. et al. Vascular wall-resident CD44+ multipotent stem cells give rise to pericytes and smooth muscle cells and contribute to new vessel maturation. PLoS ONE 6, e20540 (2011).
Tang, Z. et al. Differentiation of multipotent vascular stem cells contributes to vascular diseases. Nat.Commun. 3, 875 (2012).
Psaltis, P. J. et al. Characterization of a resident population of adventitial macrophage progenitor cells in postnatal vasculature. Circ. Res. 115, 364–375 (2014).
Ingram, D. A. et al. Vessel wall-derived endothelial cells rapidly proliferate because they contain a complete hierarchy of endothelial progenitor cells. Blood 105, 2783–2786 (2005).
Stapor, P. C., Sweat, R. S., Dashti, D. C., Betancourt, A. M. & Murfee, W. L. Pericyte dynamics during angiogenesis: new insights from new identities. J. Vasc. Res. 51, 163–174 (2014).
Hu, Y. et al. Abundant progenitor cells in the adventitia contribute to atherosclerosis of vein grafts in ApoE-deficient mice. J. Clin. Invest. 113, 1258–1265 (2004).
Psaltis, P. J. & Simari, R. D. Vascular wall progenitor cells in health and disease. Circ. Res. 116, 1392–1412 (2015).
Armulik, A., Genove, G. & Betsholtz, C. Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev. Cell 21, 193–215 (2011).
Gerhardt, H. & Betsholtz, C. Endothelial-pericyte interactions in angiogenesis. Cell Tissue Res. 314, 15–23 (2003).
Kelly-Goss, M. R., Sweat, R. S., Stapor, P. C., Peirce, S. M. & Murfee, W. L. Targeting pericytes for angiogenic therapies. Microcirculation 21, 345–357 (2014).
Katare, R. et al. Transplantation of human pericyte progenitor cells improves the repair of infarcted heart through activation of an angiogenic program involving micro-RNA-132. Circ. Res. 109, 894–906 (2011).
Chen, C. W. et al. Human pericytes for ischemic heart repair. Stem Cell 31, 305–316 (2013).
Ubil, E. et al. Mesenchymal-endothelial transition contributes to cardiac neovascularization. Nature 514, 585–590 (2014).
Li, J. et al. VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis. Am. J. Physiol. 270, H1803–H1811 (1996).
Levy, A. P. Hypoxic regulation of VEGF mRNA stability by RNA-binding proteins. Trends Cardiovasc. Med. 8, 246–250 (1998).
Ahn, A., Frishman, W. H., Gutwein, A., Passeri, J. & Nelson, M. Therapeutic angiogenesis: a new treatment approach for ischemic heart disease–part II. Cardiol. Rev. 16, 219–229 (2008).
Ahn, A., Frishman, W. H., Gutwein, A., Passeri, J. & Nelson, M. Therapeutic angiogenesis: a new treatment approach for ischemic heart disease–part I. Cardiol. Rev 16, 163–171 (2008).
Virag, J. I. & Murry, C. E. Myofibroblast and endothelial cell proliferation during murine myocardial infarct repair. Am. J. Pathol. 163, 2433–2440 (2003).
Ren, G., Michael, L. H., Entman, M. L. & Frangogiannis, N. G. Morphological characteristics of the microvasculature in healing myocardial infarcts. J. Histochem. Cytochem. 50, 71–79 (2002).
Wang, Y. et al. Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis. Nature 465, 483–486 (2010).
He, L., Tian, X., Zhang, H., Wythe, J. D. & Zhou, B. Fabp4-CreER lineage tracing reveals two distinctive coronary vascular populations. J. Cell Mol. Med. 18, 2152–2156 (2014).
Zhao, L. et al. Notch signaling regulates cardiomyocyte proliferation during zebrafish heart regeneration. Proc. Natl Acad. Sci. USA 111, 1403–1408 (2014).
Augustin, H. G. & Koh, G. Y. Organotypic vasculature: from descriptive heterogeneity to functional pathophysiology. Science 357, eaal2379 (2017).
Sacilotto, N. et al. Analysis of Dll4 regulation reveals a combinatorial role for Sox and Notch in arterial development. Proc. Natl Acad. Sci. USA 110, 11893–11898 (2013).
Neal, A. et al. Venous identity requires BMP signalling through ALK3. Nat. Commun. 10, 453 (2019).
Pfaltzgraff, E. R. & Bader, D. M. Heterogeneity in vascular smooth muscle cell embryonic origin in relation to adult structure, physiology, and disease. Dev. Dyn. 244, 410–416 (2015).
Habib, A., Lachman, N., Christensen, K. N. & Asirvatham, S. J. The anatomy of the coronary sinus venous system for the cardiac electrophysiologist. Europace 11, v15–v21 (2009).
Claxton, S. et al. Efficient, inducible Cre-recombinase activation in vascular endothelium. Genesis. 46, 74–80 (2008).
Miquerol, L. et al. Endothelial plasticity drives arterial remodeling within the endocardium after myocardial infarction. Circ. Res. 116, 1765–1771 (2015).
Kobayashi, K. et al. Dynamics of angiogenesis in ischemic areas of the infarcted heart. Sci. Rep. 7, 7156 (2017).
Swinkels, B. M., Boersma, L. V., Rensing, B. J. & Jaarsma, W. Isolated left ventricular noncompaction in a patient presenting with a subacute myocardial infarction. Neth. Heart J. 15, 109–111 (2007).
Lin, L. Y. et al. Endocardial remodeling in heart failure patients with impaired and preserved left ventricular systolic function–a magnetic resonance image study. Sci. Rep. 6, 20868 (2016).
Tang, J. et al. Genetic fate mapping defines the vascular potential of endocardial cells in the adult heart. Circ. Res. 122, 984–993 (2018).
Li, Z. et al. Single-cell transcriptome analyses reveal novel targets modulating cardiac neovascularization by resident endothelial cells following myocardial infarction. Eur. Heart J. 40, 2507–2520 (2019).
Manavski, Y. et al. Clonal expansion of endothelial cells contributes to ischemia-induced neovascularization. Circ. Res. 122, 670–677 (2018).
Guo, L., Zhang, H., Hou, Y., Wei, T. & Liu, J. Plasmalemma vesicle-associated protein: a crucial component of vascular homeostasis. Exp. Ther.Med. 12, 1639–1644 (2016).
Carson-Walter, E. B. et al. Plasmalemmal vesicle associated protein-1 is a novel marker implicated in brain tumor angiogenesis. Clin. Cancer Res. 11, 7643–7650 (2005).
Keuschnigg, J. et al. The prototype endothelial marker PAL-E is a leukocyte trafficking molecule. Blood 114, 478–484 (2009).
Kocijan, T. et al. Genetic lineage tracing reveals poor angiogenic potential of cardiac endothelial cells. Cardiovasc. Res. https://doi.org/10.1093/cvr/cvaa012 (2020).
Zhou, B. et al. Adult mouse epicardium modulates myocardial injury by secreting paracrine factors. J. Clin. Invest. 121, 1894–1904 (2011).
Zhao, T., Zhao, W., Chen, Y., Ahokas, R. A. & Sun, Y. Vascular endothelial growth factor (VEGF)-A: role on cardiac angiogenesis following myocardial infarction. Microvasc. Res. 80, 188–194 (2010).
Yang, Z. et al. Paracrine factors secreted by endothelial progenitor cells prevent oxidative stress-induced apoptosis of mature endothelial cells. Atherosclerosis 211, 103–109 (2010).
Takahashi, M. et al. Cytokines produced by bone marrow cells can contribute to functional improvement of the infarcted heart by protecting cardiomyocytes from ischemic injury. Am. J. Physiol. Heart Circ. Physiol. 291, H886–H893 (2006).
Claesson-Welsh, L. Vascular permeability–the essentials. Upsala J. Med. Sci. 120, 135–143 (2015).
Thiagarajan, H., Thiyagamoorthy, U., Shanmugham, I., Dharmalingam Nandagopal, G. & Kaliyaperumal, A. Angiogenic growth factors in myocardial infarction: a critical appraisal. Heart Fail. Rev. 22, 665–683 (2017).
Pontes-Quero, S. et al. High mitogenic stimulation arrests angiogenesis. Nat. Commun. 10, 2016 (2019).
Zangi, L. et al. Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction. Nat. Biotechnol. 31, 898–907 (2013).
Nieminen, T. et al. The impact of the receptor binding profiles of the vascular endothelial growth factors on their angiogenic features. Biochim. Biophys. Acta 1840, 454–463 (2014).
Nurro, J. et al. AdVEGF-B186 and AdVEGF-DΔNΔC induce angiogenesis and increase perfusion in porcine myocardium. Heart 102, 1716–1720 (2016).
Vieira, J. M. et al. The cardiac lymphatic system stimulates resolution of inflammation following myocardial infarction. J. Clin. Invest. 128, 3402–3412 (2018).
Hartikainen, J. et al. Adenoviral intramyocardial VEGF-DΔNΔC gene transfer increases myocardial perfusion reserve in refractory angina patients: a phase I/IIa study with 1-year follow-up. Eur. Heart J. 38, 2547–2555 (2017).
Crawford, Y. et al. PDGF-C mediates the angiogenic and tumorigenic properties of fibroblasts associated with tumors refractory to anti-VEGF treatment. Cancer Cell 15, 21–34 (2009).
Rigamonti, N. et al. Role of angiopoietin-2 in adaptive tumor resistance to VEGF signaling blockade. Cell Rep. 8, 696–706 (2014).
Casanovas, O., Hicklin, D. J., Bergers, G. & Hanahan, D. Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors. Cancer Cell 8, 299–309 (2005).
Paku, S. & Paweletz, N. First steps of tumor-related angiogenesis. Lab. Invest. 65, 334–346 (1991).
Benjamin, L. E., Hemo, I. & Keshet, E. A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development 125, 1591–1598 (1998).
House, S. L. et al. Endothelial fibroblast growth factor receptor signaling is required for vascular remodeling following cardiac ischemia-reperfusion injury. Am. J. Physiol. Heart Circ. Physiol. 310, H559–H571 (2016).
Nissen, L. J. et al. Angiogenic factors FGF2 and PDGF-BB synergistically promote murine tumor neovascularization and metastasis. J. Clin. Invest. 117, 2766–2777 (2007).
Hosaka, K. et al. Dual roles of endothelial FGF-2-FGFR1-PDGF-BB and perivascular FGF-2-FGFR2-PDGFRβ signaling pathways in tumor vascular remodeling. Cell Discov. 4, 3 (2018).
Cao, R. et al. Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2. Nat. Med. 9, 604–613 (2003).
Khand, A. et al. The collateral circulation of the heart in coronary total arterial occlusions in man: systematic review of assessment and pathophysiology. Am. Heart J. 166, 941–952 (2013).
He, L. et al. Genetic lineage tracing discloses arteriogenesis as the main mechanism for collateral growth in the mouse heart. Cardiovasc. Res. 109, 419–430 (2016).
Zhang, H. & Faber, J. E. De-novo collateral formation following acute myocardial infarction: dependence on CCR2+ bone marrow cells. J. Mol. Cell Cardiol. 87, 4–16 (2015).
Loffredo, S., Staiano, R. I., Granata, F., Genovese, A. & Marone, G. Immune cells as a source and target of angiogenic and lymphangiogenic factors. Chem. Immunol. Allergy 99, 15–36 (2014).
Fantin, A. et al. Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction. Blood 116, 829–840 (2010).
Hinkel, R. et al. MRTF-A controls vessel growth and maturation by increasing the expression of CCN1 and CCN2. Nat. Commun. 5, 3970 (2014).
Kikuchi, K. et al. tcf21+ epicardial cells adopt non-myocardial fates during zebrafish heart development and regeneration. Development 138, 2895–2902 (2011).
Lepilina, A. et al. A dynamic epicardial injury response supports progenitor cell activity during zebrafish heart regeneration. Cell 127, 607–619 (2006).
Marin-Juez, R. et al. Coronary revascularization during heart regeneration is regulated by epicardial and endocardial cues and forms a scaffold for cardiomyocyte repopulation. Dev. Cell 51, 503–515.e4 (2019).
Henry, T. D. et al. Intracoronary administration of recombinant human vascular endothelial growth factor to patients with coronary artery disease. Am. Heart J. 142, 872–880 (2001).
Losordo, D. W. et al. Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation 98, 2800–2804 (1998).
Vale, P. R. et al. Randomized, single-blind, placebo-controlled pilot study of catheter-based myocardial gene transfer for therapeutic angiogenesis using left ventricular electromechanical mapping in patients with chronic myocardial ischemia. Circulation 103, 2138–2143 (2001).
Rosengart, T. K. et al. Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease. Circulation 100, 468–474 (1999).
Fuchs, S. et al. A randomized, double-blind, placebo-controlled, multicenter, pilot study of the safety and feasibility of catheter-based intramyocardial injection of AdVEGF121 in patients with refractory advanced coronary artery disease. Catheter. Cardiovasc. Interv. 68, 372–378 (2006).
Tio, R. A. et al. PET for evaluation of differential myocardial perfusion dynamics after VEGF gene therapy and laser therapy in end-stage coronary artery disease. J. Nucl. Med. 45, 1437–1443 (2004).
Losordo, D. W. et al. Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia. Circulation 105, 2012–2018 (2002).
Hedman, M. et al. Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: phase II results of the Kuopio Angiogenesis Trial (KAT). Circulation 107, 2677–2683 (2003).
Hedman, M. et al. Eight-year safety follow-up of coronary artery disease patients after local intracoronary VEGF gene transfer. Gene. Ther. 16, 629–634 (2009).
Kastrup, J. et al. Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris: a randomized double-blind placebo-controlled study: the Euroinject One trial. J. Am. Coll. Cardiol. 45, 982–988 (2005).
Kastrup, J. et al. A randomised, double-blind, placebo-controlled, multicentre study of the safety and efficacy of BIOBYPASS (AdGVVEGF121.10NH) gene therapy in patients with refractory advanced coronary artery disease: the NOVA trial. EuroIntervention 6, 813–818 (2011).
Grines, C. L. et al. Angiogenic gene therapy (AGENT) trial in patients with stable angina pectoris. Circulation 105, 1291–1297 (2002).
Schumacher, B., Pecher, P., von Specht, B. U. & Stegmann, T. Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease. Circulation 97, 645–650 (1998).
Sellke, F. W., Laham, R. J., Edelman, E. R., Pearlman, J. D. & Simons, M. Therapeutic angiogenesis with basic fibroblast growth factor: technique and early results. Ann. Thorac. Surg. 65, 1540–1544 (1998).
Laham, R. J. et al. Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: results of a phase I randomized, double-blind, placebo-controlled trial. Circulation 100, 1865–1871 (1999).
Laham, R. J. et al. Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: results of a phase I open-label dose escalation study. J. Am. Coll. Cardiol. 36, 2132–2139 (2000).
Unger, E. F. et al. Effects of a single intracoronary injection of basic fibroblast growth factor in stable angina pectoris. Am. J. Cardiol. 85, 1414–1419 (2000).
Henry, T. D. et al. Effects of Ad5FGF-4 in patients with angina: an analysis of pooled data from the AGENT-3 and AGENT-4 trials. J. Am. Coll. Cardiol. 50, 1038–1046 (2007).
Kukula, K. et al. Intramyocardial plasmid-encoding human vascular endothelial growth factor A165/basic fibroblast growth factor therapy using percutaneous transcatheter approach in patients with refractory coronary artery disease (VIF-CAD). Am. Heart J. 161, 581–589 (2011).
Ripa, R. S. et al. Intramyocardial injection of vascular endothelial growth factor-A165 plasmid followed by granulocyte-colony stimulating factor to induce angiogenesis in patients with severe chronic ischaemic heart disease. Eur. Heart J. 27, 1785–1792 (2006).
Merki, E. et al. Epicardial retinoid X receptor α is required for myocardial growth and coronary artery formation. Proc.Natl Acad Sci. USA 102, 18455–18460 (2005).
The authors are supported by funding from the British Heart Foundation: a DPhil studentship to I.-E. L. (FS/12/69/30008), a senior fellowship to S.D.V. (FS/17/35/32929), an Ian Fleming fellowship to N.S. (FS/19/32/34376), and project grants to S.D.V. and N.S. (PG/16/34/32135 and PG/18/62/33967). The authors are also supported by the Oxbridge BHF Centre of Regenerative Medicine (RM/17/2/33380) and the BHF Oxford Centre of Research Excellence (RE/13/1/30181).
The authors declare no competing interests.
Peer review information
Nature Reviews Cardiology thanks B. Zhou, F. Sellke and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The process by which new blood vessels arise from pre-existing vessels, typically by sprouting or splitting.
The remodelling of pre-existing, interconnecting vessels into larger arteries. During development, this process is accompanied by mural cell recruitment.
The formation of new blood vessel networks capable of perfusion, for example, to replace those damaged by myocardial infarction.
- Vascular plexus
A primitive network of vessels that forms initially during development before undergoing differentiation and remodelling to give rise to vessels of different sizes and types.
- Proepicardial organ
A transient developmental outgrowth of mesothelial cells arising in the region of the septum transversum (embryonic days 8.5–9.5 in mice). Cells of the proepicardium delaminate over the outer surface of the heart to give rise to the epicardium.
- Septum transversum
A sheet of mesoderm-derived tissue that forms in the mammalian embryo to separate the thoracic and abdominal cavities. Later in development, the septum transversum gives rise to the diaphragm and ventral mesentery.
A mesothelial layer of cells on the outer surface of the heart, which contributes progenitor cells to the embryonic heart and stimulates sprouting of vessels from the sinus venosus.
- Sinus venosus
The venous inflow tract of the embryonic heart that is continuous with the atria. The sinus venosus contributes a large proportion of coronary endothelial cells during embryonic stages. Later in development, the sinus venosus is incorporated into right atrium and coronary sinus veins.
- Cre–loxP-based cell lineage tracing
A bacteriophage recombination system that is used predominantly in mouse and fish studies to genetically label a cell and trace its progeny.
The innermost layer of tissue that lines the chambers of the heart, comprising a specialized type of endothelial cell.
- Single-cell RNA sequencing
The sequencing of an entire transcriptome at the level of individual cells to reveal heterogeneity between different cells, for example, those that make up a particular tissue or organism.
- Blood island
A cluster of primitive erythroblasts surrounded by an endothelial covering that gives rise to early blood-filled vessels.
- Mural cells
Support cells that surround the endothelium of blood vessels, with important roles in vessel development, homeostasis and stability. Mural cells include pericytes of the microcirculation and vascular smooth muscle cells that densely surround large arteries in multiple layers.
- Collateral artery
New arterial segments that bridge two original arteries, forming a natural bypass to ensure blood flow downstream of an obstruction.
Mural support cells that wrap around the endothelium of capillaries and venules, and have important homeostatic roles in vessel maintenance and regulation of blood flow.
- Epithelial-to-mesenchymal transition
A process by which epithelial cells, such as those of the epicardium, lose polarity and cell–cell contacts and transition into mesenchymal cells, characterized by a more migratory phenotype, which subsequently differentiate into fibroblasts or mural cells (in the case of epicardium-derived cells).
- Neural crest
A transient embryonic cell lineage that gives rise to the peripheral nervous system, as well as non-neural cell types, including vascular smooth muscle cells, pigment cells and cells of craniofacial bones, cartilage and connective tissue.
- Endothelial progenitor cells
Circulating cells that express some markers that define vascular endothelial cells, as well as markers associated with some stem cells, and are thus considered a type of progenitor cell. Upon appropriate stimulation, endothelial progenitor cells have been shown to differentiate into endothelial-like cells in vitro.
The sprouting of capillaries into the ischaemic region and transformation into arteries by recruitment of vascular smooth muscle cells.
- Clonal expansion
Formation of a group of identical cells that arises from a single cell by proliferation.
- Endothelial-to-mesenchymal transition
The transformation of endothelial cells into mesenchymal cells, which can subsequently differentiate into fibroblasts or mural cells.
A region of the heart that receives blood from distal branches of two large coronary arteries, such as the capillary network at the anterior midline of the heart.
- Mitogenic stimulation
Treatment with one or more growth factors, typically peptides, to induce a cell to undergo division and proliferate.
About this article
Cite this article
Lupu, IE., De Val, S. & Smart, N. Coronary vessel formation in development and disease: mechanisms and insights for therapy. Nat Rev Cardiol 17, 790–806 (2020). https://doi.org/10.1038/s41569-020-0400-1
STEM CELLS Translational Medicine (2020)